Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387671913> ?p ?o ?g. }
- W4387671913 abstract "Gliomas are highly fatal malignant brain tumors with prognostically relevant molecular subtypes. Genomic instability is a hallmark of cancer, including glioma, and DNA repair mechanisms are crucial to maintaining cell integrity. Temozolomide (TMZ), which utilizes specific DNA repair pathways in its mechanism of action, is one of the few standard-of-care drugs with a meaningful impact on IDH wildtype glioblastoma survival. However, its utility in non-glioblastomas is complicated by temozolomide-induced hypermutation. This study aims to identify if germline polymorphisms in DNA repair genes are associated with overall survival within glioma subtypes and if the polymorphisms modify survival in subjects treated with temozolomide. We utilized genotype data of 2078 adults with glioma collected through the UCSF Adult Glioma Study, Mayo Clinic, and TCGA, to study 1393 SNPs within 22 specific DNA repair genes on overall survival for all cases and for those with/without temozolomide exposure during first course of treatment. All models were fit separately for individuals grouped by major molecular subtypes. We identified four germline SNPs (within MLH1, MSH4, MSH3, and MUTYH) with a significant (p<0.00019) polygenic effect on survival, where the presence of at least one SNP decreased overall survival among grade 2 and 3 glioma cases with IDH mutated tumors (Hazard ratio per unit increase in number of present polymorphic sites, HR-PS=1.52, 95% confidence interval, CI: 1.26-1.83, p=1.3x10-5). In IDH mutant gliomas without somatic 1p/19q chromosomal arm codeletion, we identified a group of SNPs (in MSH4, ERCC2, and ERCC1) which showed a stepwise significant improvement on overall survival for each present germline polymorphism (HR-PS=0.67, 95% CI: 0.56-0.80, p=8.9x10-6). Within IDH mutant glioma cases, we also identified two mutations (rs1540354-T in MLH1, rs71636247-G in MSH3) which were significantly associated with decreased overall survival only amongst those with known temozolomide usage (HR-PS=2.23, 95% CI: 1.55-3.20, p=1.56x10-5), with no survival effect observed in the non-temozolomide group (HR=0.90, 95% CI: 0.63-1.28, p=0.56). One SNP in MSH2 was suggestively associated (p<0.005) with altered IDH wildtype glioblastoma response to temozolomide (rs149630102-T, HR=1.74, 95% CI: 1.27-2.39, p=0.00052). Suggestive associations for other glioma subtypes are also reported. We found evidence that germline polygenic alterations within DNA repair pathways may alter prognosis and potentially modulate temozolomide toxicity in adults with glioma. Further validation and functional work are warranted to assess if these markers can assist clinicians in individually tailoring therapeutic treatments for adults with glioma tumors." @default.
- W4387671913 created "2023-10-17" @default.
- W4387671913 creator A5023943352 @default.
- W4387671913 creator A5027623030 @default.
- W4387671913 creator A5031603638 @default.
- W4387671913 creator A5033073004 @default.
- W4387671913 creator A5035181181 @default.
- W4387671913 creator A5038840836 @default.
- W4387671913 creator A5039387612 @default.
- W4387671913 creator A5052248018 @default.
- W4387671913 creator A5054987661 @default.
- W4387671913 creator A5055941002 @default.
- W4387671913 creator A5060720802 @default.
- W4387671913 creator A5061164702 @default.
- W4387671913 creator A5069788891 @default.
- W4387671913 creator A5073537354 @default.
- W4387671913 creator A5074499114 @default.
- W4387671913 creator A5076569275 @default.
- W4387671913 creator A5083711110 @default.
- W4387671913 creator A5093070463 @default.
- W4387671913 creator A5093070464 @default.
- W4387671913 creator A5093070465 @default.
- W4387671913 date "2023-10-15" @default.
- W4387671913 modified "2023-10-17" @default.
- W4387671913 title "The impact of germline variants in DNA repair pathways on survival and temozolomide toxicity in adults with glioma" @default.
- W4387671913 doi "https://doi.org/10.1101/2023.10.13.23296963" @default.
- W4387671913 hasPublicationYear "2023" @default.
- W4387671913 type Work @default.
- W4387671913 citedByCount "0" @default.
- W4387671913 crossrefType "posted-content" @default.
- W4387671913 hasAuthorship W4387671913A5023943352 @default.
- W4387671913 hasAuthorship W4387671913A5027623030 @default.
- W4387671913 hasAuthorship W4387671913A5031603638 @default.
- W4387671913 hasAuthorship W4387671913A5033073004 @default.
- W4387671913 hasAuthorship W4387671913A5035181181 @default.
- W4387671913 hasAuthorship W4387671913A5038840836 @default.
- W4387671913 hasAuthorship W4387671913A5039387612 @default.
- W4387671913 hasAuthorship W4387671913A5052248018 @default.
- W4387671913 hasAuthorship W4387671913A5054987661 @default.
- W4387671913 hasAuthorship W4387671913A5055941002 @default.
- W4387671913 hasAuthorship W4387671913A5060720802 @default.
- W4387671913 hasAuthorship W4387671913A5061164702 @default.
- W4387671913 hasAuthorship W4387671913A5069788891 @default.
- W4387671913 hasAuthorship W4387671913A5073537354 @default.
- W4387671913 hasAuthorship W4387671913A5074499114 @default.
- W4387671913 hasAuthorship W4387671913A5076569275 @default.
- W4387671913 hasAuthorship W4387671913A5083711110 @default.
- W4387671913 hasAuthorship W4387671913A5093070463 @default.
- W4387671913 hasAuthorship W4387671913A5093070464 @default.
- W4387671913 hasAuthorship W4387671913A5093070465 @default.
- W4387671913 hasBestOaLocation W43876719131 @default.
- W4387671913 hasConcept C104317684 @default.
- W4387671913 hasConcept C111425858 @default.
- W4387671913 hasConcept C126322002 @default.
- W4387671913 hasConcept C134935766 @default.
- W4387671913 hasConcept C13514818 @default.
- W4387671913 hasConcept C135763542 @default.
- W4387671913 hasConcept C143998085 @default.
- W4387671913 hasConcept C153209595 @default.
- W4387671913 hasConcept C207103383 @default.
- W4387671913 hasConcept C2777389519 @default.
- W4387671913 hasConcept C2778227246 @default.
- W4387671913 hasConcept C2779527866 @default.
- W4387671913 hasConcept C33288867 @default.
- W4387671913 hasConcept C44249647 @default.
- W4387671913 hasConcept C501734568 @default.
- W4387671913 hasConcept C502942594 @default.
- W4387671913 hasConcept C54355233 @default.
- W4387671913 hasConcept C60748783 @default.
- W4387671913 hasConcept C71924100 @default.
- W4387671913 hasConcept C86803240 @default.
- W4387671913 hasConcept C91965660 @default.
- W4387671913 hasConceptScore W4387671913C104317684 @default.
- W4387671913 hasConceptScore W4387671913C111425858 @default.
- W4387671913 hasConceptScore W4387671913C126322002 @default.
- W4387671913 hasConceptScore W4387671913C134935766 @default.
- W4387671913 hasConceptScore W4387671913C13514818 @default.
- W4387671913 hasConceptScore W4387671913C135763542 @default.
- W4387671913 hasConceptScore W4387671913C143998085 @default.
- W4387671913 hasConceptScore W4387671913C153209595 @default.
- W4387671913 hasConceptScore W4387671913C207103383 @default.
- W4387671913 hasConceptScore W4387671913C2777389519 @default.
- W4387671913 hasConceptScore W4387671913C2778227246 @default.
- W4387671913 hasConceptScore W4387671913C2779527866 @default.
- W4387671913 hasConceptScore W4387671913C33288867 @default.
- W4387671913 hasConceptScore W4387671913C44249647 @default.
- W4387671913 hasConceptScore W4387671913C501734568 @default.
- W4387671913 hasConceptScore W4387671913C502942594 @default.
- W4387671913 hasConceptScore W4387671913C54355233 @default.
- W4387671913 hasConceptScore W4387671913C60748783 @default.
- W4387671913 hasConceptScore W4387671913C71924100 @default.
- W4387671913 hasConceptScore W4387671913C86803240 @default.
- W4387671913 hasConceptScore W4387671913C91965660 @default.
- W4387671913 hasLocation W43876719131 @default.
- W4387671913 hasOpenAccess W4387671913 @default.
- W4387671913 hasPrimaryLocation W43876719131 @default.
- W4387671913 hasRelatedWork W1963729549 @default.
- W4387671913 hasRelatedWork W1969520081 @default.
- W4387671913 hasRelatedWork W1990997057 @default.
- W4387671913 hasRelatedWork W2007276591 @default.